438 related articles for article (PubMed ID: 30660629)
1. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.
Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J
J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization.
Wang B; Tang Y; Oh Y; Lamb NW; Xia S; Ding Z; Chen B; Suarez MJ; Meng T; Kulkarni V; Eberhart CG; Ensign LM; Stark WJ; Hanes J; Xu Q
Nanomedicine; 2019 Apr; 17():119-123. PubMed ID: 30677499
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
Papangkorn K; Prendergast E; Higuchi JW; Brar B; Higuchi WI
J Ocul Pharmacol Ther; 2017 Dec; 33(10):753-762. PubMed ID: 29022761
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
Pan Q; Xu Q; Boylan NJ; Lamb NW; Emmert DG; Yang JC; Tang L; Heflin T; Alwadani S; Eberhart CG; Stark WJ; Hanes J
J Control Release; 2015 Mar; 201():32-40. PubMed ID: 25576786
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone sodium phosphate loaded nanoparticles for prevention of nitrogen mustard induced corneal injury.
Poudel S; Kaffash E; Zhao L; Pangeni R; Chow WN; Xu Q
Exp Eye Res; 2024 Jun; 243():109902. PubMed ID: 38641196
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K
Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
[TBL] [Abstract][Full Text] [Related]
8. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
9. A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitis.
Zhou J; Yang J; Dai M; Lin D; Zhang R; Liu H; Yu A; Vakal S; Wang Y; Li X
Biochem Pharmacol; 2020 Oct; 180():114108. PubMed ID: 32569628
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes.
Zhang R; Qian J; Li X; Yuan Y
Br J Ophthalmol; 2017 Dec; 101(12):1731-1738. PubMed ID: 28986343
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone for ocular inflammation.
Saraiya NV; Goldstein DA
Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
[TBL] [Abstract][Full Text] [Related]
13. Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis.
Whitcup SM; Robinson MR
Ann N Y Acad Sci; 2015 Nov; 1358():1-12. PubMed ID: 26200808
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models.
Kodama M; Numaga J; Yoshida A; Kaburaki T; Oshika T; Fujino Y; Wu GS; Rao NA; Kawashima H
Graefes Arch Clin Exp Ophthalmol; 2003 Nov; 241(11):927-33. PubMed ID: 14652765
[TBL] [Abstract][Full Text] [Related]
15. Calcium ion coordinated dexamethasone supramolecular hydrogel as therapeutic alternative for control of non-infectious uveitis.
Wu W; Zhang Z; Xiong T; Zhao W; Jiang R; Chen H; Li X
Acta Biomater; 2017 Oct; 61():157-168. PubMed ID: 28501709
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus-Loaded Intravitreal Implant for Effective Treatment of Experimental Uveitis.
Paiva MRB; Vasconcelos-Santos DV; Vieira LC; Fialho SL; Silva-Cunha A
AAPS PharmSciTech; 2021 Jan; 22(1):35. PubMed ID: 33404988
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival injection of rapamycin-loaded polymeric microparticles for effective suppression of noninfectious uveitis in rats.
Mo L; Deng M; Chen J; Huai S; Du L; Xu X; Guo Q; Chen H; Li X; Bao Z
Int J Pharm; 2024 May; 657():124178. PubMed ID: 38692499
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model.
Wu W; He Z; Zhang Z; Yu X; Song Z; Li X
Int J Pharm; 2016 Nov; 513(1-2):238-246. PubMed ID: 27609662
[TBL] [Abstract][Full Text] [Related]
19. Sustained release ophthalmic dexamethasone: In vitro in vivo correlations derived from the PK-Eye.
Awwad S; Day RM; Khaw PT; Brocchini S; Fadda HM
Int J Pharm; 2017 Apr; 522(1-2):119-127. PubMed ID: 28232270
[TBL] [Abstract][Full Text] [Related]
20. A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis.
De Majumdar S; Subinya M; Korward J; Pettigrew A; Scherer D; Xu H
Curr Mol Med; 2017; 17(3):211-220. PubMed ID: 28782485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
